Stay updated with breaking news from Trials Unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
STUDENTS who have played a leading part in the world's largest trials in the battle against Covid-19 have been recognised for their work by the…
A quarterly e-newsletter from the Centers for Disease Control and Prevention's (CDC) Office of Minority Health and Health Equity (OMHHE) sharing news, perspectives and progress in the science and practice of health equity.
The study, published today in The New England Journal of Medicine, found that dolutegravir-based regimens, which are already widely used to treat adults, reduced the chances of treatment failure among young people aged three to 18 by around 40% compa
A once-a-day antiretroviral medicine that is low-cost and easy for children to take is also more effective at suppressing HIV than standard treatments, according to a global trial led by researchers at UCL.
A study has found that the once-a-day dolutegravir-based regimen reduced the chances of treatment failure in those aged 3-18 by around 40%.